[The effect of catecholaminergic substances on behavior and the EEG in rats with corazole seizures].
D000661:Amphetamine / Q000627:therapeutic use*; D000818:Animals; D000927:Anticonvulsants; D001058:Apomorphine / Q000627:therapeutic use*; D001921:Brain / Q000503:physiopathology*; D002746:Chlorpromazine / Q000633:toxicity*; D003292:Convulsants; D003342:Corpus Striatum / Q000503:physiopathology; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D004221:Disulfiram / Q000627:therapeutic use* / Q000633:toxicity; D004347:Drug Interactions; D004569:Electroencephalography; D006220:Haloperidol / Q000633:toxicity*; D006624:Hippocampus / Q000503:physiopathology; D008297:Male; D008636:Mesencephalon / Q000503:physiopathology; D008750:Methyldopa / Q000633:toxicity*; D009778:Occipital Lobe / Q000503:physiopathology; D010433:Pentylenetetrazole; D051381:Rats; D012154:Reticular Formation / Q000503:physiopathology; D012640:Seizures / Q000139:chemically induced* / Q000503:physiopathology / Q000517:prevention & control
D000927:Anticonvulsants; D003292:Convulsants; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D000661:Amphetamine; D006220:Haloperidol; D001058:Apomorphine; D004221:Disulfiram; D002746:Chlorpromazine; D010433:Pentylenetetrazole
Vliianie katekholaminergicheskikh veshchestv na povedenie i EEG pri korazolovykh sudorogakh u krys